Kaempferol activity on <i>Cryptosporidium parvum</i> infection in an experimentally infected immunocompromised mouse model: <i>In silico</i> and <i>in vivo</i> investigations
KPF demonstrated the potential to mitigate the consequences of cryptosporidiosis and serve as an adjuvant agent to NTZ by reducing the oocyst burden, alleviating intestinal inflammation, and facilitating mucosal repair.
Authors
- Eman S. El-Wakil (ORCID: https://orcid.org/0000-0002-0082-9412)
- Muslimah N. Alsulami (ORCID: https://orcid.org/0000-0002-0447-8963)
- Majed Hamdi Wakid (ORCID: https://orcid.org/0000-0003-4941-5373)
- Haytham Azab
Institutions
- Misr University for Science and Technology (EG)
- King Abdulaziz University (SA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Abdulaziz Medical City (SA)
- University of Jeddah (SA)
- Theodor Bilharz Research Institute (EG)
Publication Details
- Journal
- Pharmaceutical Biology
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1080/13880209.2025.2603384
- Primary Topic
- Parasitic Infections and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00